Close Menu

Money, Money

When Congress included NIH in the Recovery and Reinvestment Act and offered money for research, scientists were happy, but also complained that two years of funding wasn't enough time to do significant research, DrugMonkey says. "I thought this was stupid. More money into the research enterprise is a good thing, in my view. It displayed a shocking lack of can-do attitude and imagination on the part of scientists to react the way they did," he adds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.